Le Lézard
Classified in: Health, Science and technology
Subject: PDT

TFDA Approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology


HSINCHU, Aug. 8, 2022 /PRNewswire/ -- NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022.

NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022.

The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi Medical Center, with the External Ventricular Drain (EVD) placement abstract results published in the well-known European journal Acta Neurochirurgica. Dr. Tsung-Lang, Chiu stated, "The results of this report show that the average time spent on the patient registration was 1423.8 seconds. The mean target deviation was 1.68mm, and the mean angular deviation was 1.99 degrees, all within the accepted tolerance for minimal tissue damage." Dr. Chiu concluded, "NaoTrac has several advantages besides the high precision, like a non-invasive, non-contact patient registration process with a fast and accurate procedure, the system provides precise navigation to the surgical target. It's also user-friendly, and has many other benefits."

NaoTrac's technology, Surface Mapping Auto-Registration Technology (SMART), merges machine vision, robotics, and A.I. to streamline surgical procedures with real-time imaging and minimal invasive outcomes. NaoTrac will be used for other surgeries like endoscopic brain surgery, cell implantation, and other operations. Brain Navi is attending the CNS Annual Meeting held in San Francisco, and the Taiwan Expo USA 2022 in Washington D.C., both in October, to showcase NaoTrac and the release of the neurosurgical endoscope.

About Brain Navi

Brain Navi Biotechnology is a leading Taiwanese surgical robotic company. We design and develop innovative navigation and robotic surgery technologies for surgeons to improve surgical accuracy. Brain Navi's exclusive Surface Mapping Auto-registration Technology (SMART) is a significant surgical robotic breakthrough that merges machine vision, robotics, and AI technology to achieve streamlined surgical procedures with real-time imaging and minimal invasive outcomes.

Photo - https://mma.prnewswire.com/media/1873023/image1.jpg
Logo - https://mma.prnewswire.com/media/1873615/Logo.jpg 


These press releases may also interest you

at 03:00
Uniform Advantage (UA), a multi-channel retailer of medical uniforms for medical and hospitality industries, is proud to continue its partnership with the Breast Cancer Research Foundation® (BCRF) with a $20,000 donation. "Uniform...

30 sep 2022
Tanger Factory Outlet Centers, Inc.  announces the launch of its annual Pink campaign this October, building upon the company's commitment to breast cancer research and local breast cancer support groups within the communities it serves. Tanger...

30 sep 2022
Lug, the popular lifestyle brand of handbags and accessories, is pleased to announce its 3-year commitment to the SickKids Foundation in support of The Hospital for Sick Children. Through our Lug Cares Program, Lug is committed to supporting and...

30 sep 2022
October is pregnancy and infant loss awareness month with the Butterfly Run kicking off the month on October 1st with a 5 km and 3 km run/walk to raise awareness about these often-silent losses. The run raises funds to help support those who have...

30 sep 2022
Regulatory News: Aptorum Group Limited ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...

30 sep 2022
Technavio's latest offering, the Motion Sickness Drugs Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The motion sickness drugs market value is anticipated to grow by USD 119.64...



News published on 7 august 2022 at 20:00 and distributed by: